Relationship between tumorigenicity and the dosage of lymphoma-vs. Normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearrangedpvt-1 gene and normal cells
- 15 August 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 44 (2) , 353-359
- https://doi.org/10.1002/ijc.2910440228
Abstract
Somatic cell hybrids were generated between YACUT, a doubly drug-resistant subline of YAC-I (a Moloney-virus-induced T-cell lymphoma of strain A/Sn origin with 2 pro viral insertions near the pvt-1 locus) and normal diploid fibroblasts of CBAT6T6 origin. Three independent fusions were performed. Three uncloned hybrid cultures and 9 independently-derived clones were tested for tumorigenicity by the inoculation of graded cell numbers into syngeneic hosts. One of 3 uncloned hybrid cultures and 3 of 9 clones were weakly tumorigenic (take incidence 0%), and 1 of 3 uncloned hybrid cultures and 6 clones were highly tumorigenic (take incidence >80%). One weakly tumorigenic hybrid and 3 weakly tumorigenic clones carried 3 copies of the tumor-derived chromosome 15 and 2 copies of the normal fibroblast-derived t(l4;l5) chromosomes. In contrast, 2 highly malignant hybrid clones lost one copy of the normal-fibroblast-derived t(14;15), but contained increased numbers (3.44-4.44) of the tumor-derived chromosome 15. Four tumorigenic segregants selected from the weakly tumorigenic fibroblast hybrids by in vivo inoculation showed the same cytogenetic change as the highly tumorigenic hybrid clones, in that the ratio of the normal:tumor-derived chromosomes 15 changed from 1.18-1.55 to 4.11-5.71. Tumorigenicity was thus associated with a modified balance between the tumor vs. the normal-parent-derived 15-chromosomes. Instead of the usual 3:2 ratio, the tumor-derived 15-chromosomes increased disproportionately, whereas the relative number of the normal-parent-derived 15-chromosome decreased, as a rule. These results suggest that amplification of the lymphoma-derived chromosome 15 favors tumorigenicity, but that this effect is counteracted by some influence emanating from the normal-parent-derived homologous chromosome.This publication has 47 references indexed in Scilit:
- Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome TranslocationPublished by Elsevier ,1986
- Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocationsNature, 1985
- Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertionCell, 1984
- Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchangeCell, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Chromosome changes in butylnitrosourea (BNU)-induced mouse leukemiaInternational Journal of Cancer, 1982
- Cytogenetics of murine thymic lymphomas induced by N-methyl-N-nitrosourea: Difference in incidence of trisomy 15 in thymic lymphomas induced in neonatal and adult miceCancer Genetics and Cytogenetics, 1981
- Trisomy #15 in Murine Thymomas Induced by Chemical Carcinogens, X-Irradiation, and an Endogenous Murine Leukemia Virus2JNCI Journal of the National Cancer Institute, 1979
- Antibodies to major histocompatibility antigens produced by hybrid cell linesNature, 1977
- Trisomy of chromosome 15 in spontaneous leukemia of AKR mice.Proceedings of the National Academy of Sciences, 1975